Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Doxorubicin-loaded dextran-based nano-carriers for highly efficient inhibition of lymphoma cell growth and synchronous reduction of cardiac toxicity.

Ying Fang | Hao Wang | Hong-Jing Dou | Xing Fan | Xiao-Chun Fei | Lei Wang | Shu Cheng | Anne Janin | Li Wang | Wei-Li Zhao
International journal of nanomedicine | 2018

Cardiac side effects of doxorubicin (Dox) have limited its clinical application. The aim of this study was to explore new Dox-loaded dextran-based nano-carriers (NCs) in efficiently targeting tumor growth with less cardiac toxicity.

Pubmed ID: 30288040

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Jurkat (tool)

RRID:CVCL_0065

Cell line Jurkat is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

H9c2(2-1) (tool)

RRID:CVCL_0286

Cell line H9c2(2-1) is a Spontaneously immortalized cell line with a species of origin Rattus norvegicus (Rat)

View all literature mentions